A Randomized Phase 3 Study of Nivolumab plus Ipilimumab or Nivolumab Combined with Fluorouracil plus Cisplatin versus Fluorouracil plus Cisplatin in Subjects with Unresectable Advanced, Recurrent or Metastatic Previously Untreated Esophageal Squamous Cell Carcinoma
| Title | A Randomized Phase 3 Study of Nivolumab plus Ipilimumab or Nivolumab Combined with Fluorouracil plus Cisplatin versus Fluorouracil plus Cisplatin in Subjects with Unresectable Advanced, Recurrent or Metastatic Previously Untreated Esophageal Squamous Cell Carcinoma |
|---|---|
| Description | Primary Clinical Study Report for Foreign Health Authority |
| Organism | Homo sapiens |
| Data Type | Other Type of Clinical information |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011366 |
| Release Date | 2022-12-31 |
| Submitter | Jianming Xu (jianmingxu2014@163.com) |
| Organization | Chinese PLA General Hospital (CPLAGH) |
| Submission Date | 2022-08-22 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX001655-02 | CA209-648 CSR Foreign HA Submission Package | 229 | Other Type of Clinical information | 8.8 MB | zip | 0 | Controlled |